Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
823 domestic filers with 5+ patents · page 2
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 51 | CENTRE OF EXCELLENCE IN WIRELESS TECHNOLOGY | 60 | 1321.7% | 0 | 47 | 2020–2026 |
| 52 | PI INDUSTRIES | 60 | 610% | 1 | 53 | 2019–2026 |
| 53 | JSW STEEL | 57 | 814% | 1 | 48 | 2022–2025 |
| 54 | MAZAGON DOCK SHIPBUILDERS | 57 | 00% | 0 | 57 | 2022–2024 |
| 55 | MINDA | 55 | 23.6% | 2 | 51 | 2022–2025 |
| 56 | OPTIMUS DRUGS | 55 | 11.8% | 11 | 43 | 2021–2024 |
| 57 | ULTRAHUMAN HEALTHCARE | 55 | 610.9% | 4 | 45 | 2022–2026 |
| 58 | WIPRO | 55 | 2443.6% | 0 | 31 | 2019–2025 |
| 59 | CEAT | 54 | 611.1% | 0 | 48 | 2019–2024 |
| 60 | ETTRICK INNOVATIONS | 53 | 00% | 12 | 41 | 2022–2024 |
| 61 | PAUL WURTH | 52 | 23.8% | 2 | 48 | 2022–2026 |
| 62 | AKUMS DRUGS PHARMACEUTICALS | 51 | 611.8% | 3 | 42 | 2022–2025 |
| 63 | PREEYARIKA INNOVATIONS | 51 | 47.8% | 4 | 43 | 2022–2024 |
| 64 | TITAN | 51 | 815.7% | 0 | 43 | 2021–2024 |
| 65 | GODREJ BOYCE MFG | 50 | 918% | 0 | 41 | 2019–2025 |
| 66 | ITC | 50 | 1326% | 0 | 37 | 2016–2026 |
| 67 | RIVER MOBILITY | 48 | 2347.9% | 2 | 23 | 2022–2026 |
| 68 | ZOHO | 48 | 510.4% | 1 | 42 | 2020–2026 |
| 69 | ENGINEERS INDIA | 47 | 919.1% | 0 | 38 | 2021–2026 |
| 70 | SIMPLEENERGY | 47 | 817% | 1 | 38 | 2022–2026 |
| 71 | STEEL AUTHORITY OF INDIA | 47 | 00% | 0 | 47 | 2022–2024 |
| 72 | RAJDHANI PETROCHEMICALS | 46 | 1226.1% | 2 | 32 | 2020–2025 |
| 73 | CIPLA | 43 | 12.3% | 5 | 37 | 2020–2025 |
| 74 | HILTI AKTIENGESELLSCHAFT | 42 | 00% | 8 | 34 | 2023–2026 |
| 75 | SHIVANI | 42 | 00% | 3 | 39 | 2022–2026 |
| 76 | ULTRAVIOLETTE AUTOMOTIVE | 42 | 1638.1% | 1 | 25 | 2022–2025 |
| 77 | ZF COMMERCIAL VEHICLE CONTROL SYSTEMS INDIA | 42 | 24.8% | 2 | 38 | 2019–2023 |
| 78 | HIGGSFLEET INNOVATIONS | 39 | 00% | 0 | 39 | 2023–2024 |
| 79 | LARSEN TOUBRO | 39 | 25.1% | 0 | 37 | 2021–2026 |
| 80 | MOREPEN LABORATORIES | 39 | 12.6% | 0 | 38 | 2020–2024 |
| 81 | NACL INDUSTRIES | 39 | 00% | 0 | 39 | 2022–2025 |
| 82 | ZEN TECHNOLOGIES | 39 | 1743.6% | 0 | 22 | 2019–2025 |
| 83 | BIORAD MEDISYS | 38 | 37.9% | 0 | 35 | 2021–2025 |
| 84 | HINDALCO INDUSTRIES | 37 | 410.8% | 0 | 33 | 2018–2024 |
| 85 | HNNOIX INDIA | 37 | 00% | 0 | 37 | 2024–2024 |
| 86 | OPTIMUS PHARMA | 37 | 00% | 8 | 29 | 2022–2024 |
| 87 | THE PRINCIPAL | 37 | 410.8% | 8 | 25 | 2022–2026 |
| 88 | BERT LABS | 36 | 38.3% | 3 | 30 | 2019–2026 |
| 89 | NEVO MOBILES | 36 | 00% | 0 | 36 | 2022–2024 |
| 90 | BHARAT PETROLEUM | 35 | 925.7% | 0 | 26 | 2022–2026 |
| 91 | COMVIVA TECHNOLOGIES | 35 | 25.7% | 0 | 33 | 2022–2026 |
| 92 | IFB INDUSTRIES | 35 | 514.3% | 2 | 28 | 2022–2026 |
| 93 | PHINIA DELPHI LUXEMBOURG | 35 | 25.7% | 0 | 33 | 2010–2026 |
| 94 | EXPONENT ENERGY | 34 | 2470.6% | 1 | 9 | 2022–2024 |
| 95 | HFCL | 34 | 38.8% | 0 | 31 | 2021–2025 |
| 96 | ALEMBIC PHARMACEUTICALS | 33 | 00% | 5 | 28 | 2022–2024 |
| 97 | GENMINDS SKILL TRAININGS AND TECHNOLOGICAL SERVICES | 33 | 00% | 0 | 33 | 2023–2024 |
| 98 | LOHUM MATERIALS | 33 | 1648.5% | 0 | 17 | 2024–2026 |
| 99 | MERAI NEWAGE | 33 | 39.1% | 0 | 30 | 2024–2026 |
| 100 | METAL STEEL FACTORY ISHAPORE | 33 | 39.1% | 0 | 30 | 2022–2024 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →